Insider · CIK 0001255348

CATLIN AVERY W

Reports to the SEC for 3 companies · HINGHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001255348

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-05-30	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director	AAward	+2,783 sh	—	—	4,350
2024-05-16	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,783 sh	—	—	2,783
2023-05-18	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−22.2K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−24K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−129K sh	—	—	0
2023-04-27	Provention Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−10K sh	—	—	0
2023-04-27	Provention Bio, Inc.U Disposition from Tender	Director	UDisposition from Tender	−10K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−33K sh	—	—	0
2023-04-27	Provention Bio, Inc.Option to Purchase Common StockD Disposition to Issuer	Director	DDisposition to Issuer	−23K sh	—	—	0
2023-04-13	Provention Bio, Inc.G Gift	Director	GGift	−10K sh	—	—	10,000
2023-04-13	Provention Bio, Inc.G Gift	Director	GGift	+10K sh	—	—	10,000
2022-05-18	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director	AAward	+79.6K sh	—	—	79,600
2022-05-17	Provention Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+33K sh	—	—	33,000
2021-06-17	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+58.2K sh	—	—	58,200
2021-06-17	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+58.2K sh	—	—	58,200
2021-05-12	Provention Bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+23K sh	—	—	23,000
2020-07-15	Provention Bio, Inc.Option (right to buy)A Award	Director	AAward	+22.2K sh	—	—	22,200
2020-05-20	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director	AAward	+40.5K sh	—	—	40,500
2019-06-24	Provention Bio, Inc.Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2019-05-22	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director	AAward	+33.3K sh	—	—	33,300
2018-12-26	Provention Bio, Inc.P Purchase	Director	PPurchase	+5,000 sh	$1.85	+$9,250	20,000
2018-12-24	Provention Bio, Inc.P Purchase	Director	PPurchase	+5,000 sh	$1.90	+$9,500	15,000
2018-11-09	Provention Bio, Inc.P Purchase	Director	PPurchase	+10K sh	$3.15	+$31.5K	10,000
2018-09-05	Provention Bio, Inc.Option (right to buy)A Award	Director	AAward	+129K sh	—	—	128,981
2018-05-24	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director	AAward	+34K sh	—	—	34,000
2017-05-25	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director	AAward	+30.5K sh	—	—	30,500
2017-05-11	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director	PPurchase	+5,000 sh	$6.15	+$30.7K	47,000
2016-11-22	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director	PPurchase	+2,000 sh	$7.55	+$15.1K	42,000
2016-09-02	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	+10K sh	$2.80	+$28K	83,586
2016-09-02	CLDXCelldex Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	−10K sh	—	—	25,000
2016-06-08	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionA Award	Sr. VP & CFO	AAward	+135K sh	—	—	135,000
2016-06-03	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	+20K sh	$2.80	+$56K	70,739
2016-06-03	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	+2,847 sh	$4.50	+$12.8K	73,586
2016-06-03	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	−2,847 sh	—	—	5,000
2016-06-03	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	−20K sh	—	—	0
2016-05-26	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2016-03-09	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	−15K sh	—	—	20,000
2016-03-09	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	+15K sh	$2.80	+$42K	50,739
2015-11-23	CLDXCelldex Therapeutics, Inc. · Non-Qualified Stock OptionM Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	−25K sh	—	—	0
2015-11-23	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	+25K sh	$8.52	+$213K	60,109
2015-11-23	CLDXCelldex Therapeutics, Inc.S Sale	Sr. VP & CFO	SSale	−25K sh	$18.00	−$450K	35,109
2015-09-11	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	+10K sh	$4.50	+$45K	35,109
2015-09-11	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	−10K sh	—	—	7,847
2015-08-18	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director	PPurchase	+8,212 sh	$1.90	+$15.6K	40,000
2015-08-17	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director	PPurchase	+1,788 sh	$1.90	+$3,397.2	31,788
2015-08-17	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director	PPurchase	+5,000 sh	$1.94	+$9,695	25,000
2015-08-17	CRBPCorbus Pharmaceuticals Holdings, Inc.P Purchase	Director	PPurchase	+5,000 sh	$1.95	+$9,750	30,000
2015-08-12	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2015-06-15	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	Sr. VP & CFO	MExercise/Conversion	+25K sh	$8.52	+$213K	49,609

Recent filings

Accepted (ET)
Jun 34
CATLIN AVERY W0000950170-24-068035
SEC(opens sec.gov)
May 204
CATLIN AVERY W0001209191-24-005672
SEC(opens sec.gov)
May 224
CATLIN AVERY W0001209191-23-031441
SEC(opens sec.gov)
Apr 274
CATLIN AVERY W0001493152-23-013910
SEC(opens sec.gov)
Apr 144
CATLIN AVERY W0001493152-23-012387
SEC(opens sec.gov)
May 194
CATLIN AVERY W0001209191-22-030437
SEC(opens sec.gov)
May 184
CATLIN AVERY W0001493152-22-014366
SEC(opens sec.gov)
Jun 174
CATLIN AVERY W0001209191-21-041455
SEC(opens sec.gov)
May 144
CATLIN AVERY W0001493152-21-011589
SEC(opens sec.gov)
Jul 164
CATLIN AVERY W0001493152-20-013477
SEC(opens sec.gov)
May 224
CATLIN AVERY W0001209191-20-031659
SEC(opens sec.gov)
Jun 284
CATLIN AVERY W0001209191-19-039459
SEC(opens sec.gov)

Companies

Address

241 CENTRAL STREET

HINGHAM, MA, 02043